当前位置: 首页 > 详情页

Oxidized Low-Density Lipoprotein to High-Density Lipoprotein Ratio Predicts Recurrent Stroke in Minor Stroke or Transient Ischemic Attack

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Neurology ,Beijing Tiantan Hospital, Capital Medical University, China. [2]China National Clinical Research Center for Neurological Diseases Beijing Tiantan Hospital, Capital Medical University, China.
出处:
ISSN:

关键词: brain ischemia humans ischemic transient attack oxidized low density lipoprotein stroke

摘要:
Background and Purpose Oxidized low-density lipoprotein (oxLDL) level is thought to be associated with recurrent stroke. We aimed to investigate the association between oxLDL to high-density lipoprotein (HDL) ratio and recurrent stroke in patients with minor stroke or transient ischemic attack. Methods The study included 3019 patients with minor ischemic stroke or high-risk transient ischemic attack from the CHANCE trial (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events). Baseline oxLDL and HDL levels were measured. The primary outcome was any stroke within 90 days. The secondary outcomes included any stroke within 1 year and ischemic stroke and combined vascular events within 90 days and 1 year. The association between oxLDL/HDL and recurrent stroke was analyzed by using Cox proportional hazards. Results Patients in the highest oxLDL/HDL quartile had a higher risk of recurrent stroke within 90 days (hazards ratio, 1.50; 95% CI, 1.08-2.08) compared with the lowest quartile after adjusting relevant confounding factors (P=0.02). Similar results were found for secondary outcomes (P<0.05 for all). There were no significant interaction between oxLDL/HDL and use of statins agents. Conclusions Higher serum oxLDL/HDL level in minor stroke or transient ischemic attack was associated with increased risk of recurrent stroke in 90 days and 1 year. OxLDL/HDL may act as a powerful indicator of recurrent stroke in patients with minor stroke or transient ischemic attack. Clinical Trial Registration URL: http://www.clinicaltrials.gov. Unique identifier: NCT00979589.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 2 区 医学
小类 | 2 区 临床神经病学 2 区 外周血管病
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 临床神经病学 1 区 外周血管病
JCR分区:
出版当年[2016]版:
Q1 PERIPHERAL VASCULAR DISEASE Q1 CLINICAL NEUROLOGY
最新[2023]版:
Q1 CLINICAL NEUROLOGY Q1 PERIPHERAL VASCULAR DISEASE

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Department of Neurology ,Beijing Tiantan Hospital, Capital Medical University, China. [2]China National Clinical Research Center for Neurological Diseases Beijing Tiantan Hospital, Capital Medical University, China.
共同第一作者:
通讯作者:
通讯机构: [1]Department of Neurology ,Beijing Tiantan Hospital, Capital Medical University, China. [2]China National Clinical Research Center for Neurological Diseases Beijing Tiantan Hospital, Capital Medical University, China. [*1]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, No. 6 Tiantanxili, Dongcheng Dist, Beijing 100050, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院